Furthermore, inhibiting the Nrf2 signalling pathway could reverse the drug resistance and increase the sensitivity of pancreatic cancer cells to chemotherapy (Zhou et al., 2019; Kim et al., 2020). The gene discussed is NFE2L2; the disease is pancreatic neoplasm.